1. Home
  2. CKPT vs KLTR Comparison

CKPT vs KLTR Comparison

Compare CKPT & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CKPT
  • KLTR
  • Stock Information
  • Founded
  • CKPT 2014
  • KLTR 2006
  • Country
  • CKPT United States
  • KLTR United States
  • Employees
  • CKPT N/A
  • KLTR N/A
  • Industry
  • CKPT Biotechnology: Pharmaceutical Preparations
  • KLTR EDP Services
  • Sector
  • CKPT Health Care
  • KLTR Technology
  • Exchange
  • CKPT Nasdaq
  • KLTR Nasdaq
  • Market Cap
  • CKPT 361.1M
  • KLTR 319.1M
  • IPO Year
  • CKPT 2017
  • KLTR 2021
  • Fundamental
  • Price
  • CKPT $4.26
  • KLTR $2.12
  • Analyst Decision
  • CKPT Buy
  • KLTR Buy
  • Analyst Count
  • CKPT 3
  • KLTR 3
  • Target Price
  • CKPT $4.33
  • KLTR $2.83
  • AVG Volume (30 Days)
  • CKPT 2.1M
  • KLTR 293.3K
  • Earning Date
  • CKPT 05-13-2025
  • KLTR 05-08-2025
  • Dividend Yield
  • CKPT N/A
  • KLTR N/A
  • EPS Growth
  • CKPT N/A
  • KLTR N/A
  • EPS
  • CKPT N/A
  • KLTR N/A
  • Revenue
  • CKPT $41,000.00
  • KLTR $180,920,000.00
  • Revenue This Year
  • CKPT $102,182.93
  • KLTR $3.46
  • Revenue Next Year
  • CKPT $351.71
  • KLTR $3.67
  • P/E Ratio
  • CKPT N/A
  • KLTR N/A
  • Revenue Growth
  • CKPT N/A
  • KLTR 2.40
  • 52 Week Low
  • CKPT $1.80
  • KLTR $0.76
  • 52 Week High
  • CKPT $4.50
  • KLTR $2.82
  • Technical
  • Relative Strength Index (RSI)
  • CKPT 80.26
  • KLTR 48.61
  • Support Level
  • CKPT $4.14
  • KLTR $2.08
  • Resistance Level
  • CKPT $4.20
  • KLTR $2.23
  • Average True Range (ATR)
  • CKPT 0.03
  • KLTR 0.10
  • MACD
  • CKPT -0.00
  • KLTR -0.01
  • Stochastic Oscillator
  • CKPT 85.71
  • KLTR 25.45

About CKPT Checkpoint Therapeutics Inc.

Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

Share on Social Networks: